These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32963011)

  • 1. FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.
    Manfrini N; Mancino M; Miluzio A; Oliveto S; Balestra M; Calamita P; Alfieri R; Rossi RL; Sassoè-Pognetto M; Salio C; Cuomo A; Bonaldi T; Manfredi M; Marengo E; Ranzato E; Martinotti S; Cittaro D; Tonon G; Biffo S
    Cancer Res; 2020 Nov; 80(21):4693-4706. PubMed ID: 32963011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis.
    Fucci C; Resnati M; Riva E; Perini T; Ruggieri E; Orfanelli U; Paradiso F; Cremasco F; Raimondi A; Pasqualetto E; Nuvolone M; Rampoldi L; Cenci S; Milan E
    Cell Rep; 2020 Sep; 32(12):108162. PubMed ID: 32966780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma.
    Herrero AB; Quwaider D; Corchete LA; Mateos MV; García-Sanz R; Gutiérrez NC
    J Cell Mol Med; 2020 Apr; 24(7):4171-4182. PubMed ID: 32141701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells.
    Kanasugi J; Hanamura I; Ota A; Karnan S; Lam VQ; Mizuno S; Wahiduzzaman M; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Takami A
    Cancer Sci; 2020 May; 111(5):1663-1675. PubMed ID: 32176823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.
    Mroczek S; Chlebowska J; Kuliński TM; Gewartowska O; Gruchota J; Cysewski D; Liudkovska V; Borsuk E; Nowis D; Dziembowski A
    Nat Commun; 2017 Sep; 8(1):619. PubMed ID: 28931820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of
    Zhu YX; Shi CX; Bruins LA; Jedlowski P; Wang X; Kortüm KM; Luo M; Ahmann JM; Braggio E; Stewart AK
    Cancer Res; 2017 Aug; 77(16):4317-4327. PubMed ID: 28619709
    [No Abstract]   [Full Text] [Related]  

  • 7. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C.
    Zhang H; Zhang SH; Hu JL; Wu YT; Ma XY; Chen Y; Yu B; Liao S; Huang H; Gao S
    Cancer Commun (Lond); 2021 Jul; 41(7):615-630. PubMed ID: 34048638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating Autophagy.
    Mancino M; Lai G; De Grossi F; Cuomo A; Manganaro L; Butta GM; Ferrari I; Vicenzi E; Poli G; Pesce E; Oliveto S; Biffo S; Manfrini N
    Microbiol Spectr; 2023 Aug; 11(4):e0521122. PubMed ID: 37358411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
    Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Analyses of the FAM46C/Plk4 Complex.
    Chen H; Lu D; Shang G; Gao G; Zhang X
    Structure; 2020 Aug; 28(8):910-921.e4. PubMed ID: 32433990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.
    Dykstra KM; Allen C; Born EJ; Tong H; Holstein SA
    Oncotarget; 2015 Dec; 6(39):41535-49. PubMed ID: 26595805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.
    Wallington-Beddoe CT; Bennett MK; Vandyke K; Davies L; Zebol JR; Moretti PAB; Pitman MR; Hewett DR; Zannettino ACW; Pitson SM
    Oncotarget; 2017 Jul; 8(27):43602-43616. PubMed ID: 28467788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
    Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
    Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells.
    Catena V; Bruno T; De Nicola F; Goeman F; Pallocca M; Iezzi S; Sorino C; Cigliana G; Floridi A; Blandino G; Fanciulli M
    Oncotarget; 2016 Oct; 7(43):70546-70558. PubMed ID: 27655709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel autophagy inhibitor elaiophylin exerts antitumor activity against multiple myeloma with mutant TP53 in part through endoplasmic reticulum stress-induced apoptosis.
    Wang G; Zhou P; Chen X; Zhao L; Tan J; Yang Y; Fang Y; Zhou J
    Cancer Biol Ther; 2017 Aug; 18(8):584-595. PubMed ID: 28718729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
    Moriya S; Komatsu S; Yamasaki K; Kawai Y; Kokuba H; Hirota A; Che XF; Inazu M; Gotoh A; Hiramoto M; Miyazawa K
    Int J Oncol; 2015 Feb; 46(2):474-86. PubMed ID: 25422130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.
    Mishima Y; Santo L; Eda H; Cirstea D; Nemani N; Yee AJ; O'Donnell E; Selig MK; Quayle SN; Arastu-Kapur S; Kirk C; Boise LH; Jones SS; Raje N
    Br J Haematol; 2015 May; 169(3):423-34. PubMed ID: 25709080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells.
    Perini T; Materozzi M; Milan E
    FEBS J; 2022 Aug; 289(15):4383-4397. PubMed ID: 34117720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.